USPTO Publishes Request for Comments and Notice of Public Hearings on Genetic Diagnostic Testing
- Sterne, Kessler, Goldstein & Fox
The United States Patent and Trademark Office is interested in gathering information on the genetic diagnostic testing for purposes of preparing a report on the subject as required by the America Invents Act. To assist in gathering this information, the USPTO invites the public to provide comments and to attend public hearings addressing genetic diagnostic testing.
The USPTO will hold two public hearings in support of the genetic testing study. The first public hearing will be held on Thursday, February 16, 2012, beginning at 9 a.m., Eastern Standard Time (EST), and ending at 4 p.m., EST, in Alexandria, Virginia. The second public hearing will be held on Friday, March 9, 2012, beginning at 9 a.m., Pacific Standard Time (PST), and ending at 4 p.m., PST, in San Diego, California.
Those wishing to present oral testimony at either hearing must request an opportunity to do so in writing no later than February 8, 2012. Requests to testify should indicate the following: (1) The name of the person wishing to testify; (2) the person's contact information (telephone number and email address); (3) the organization(s) the person represents, if any; (4) an indication of the amount of time needed for the testimony; and (5) a preliminary written copy of the testimony. The USPTO asks for a preliminary written copy of the testimony in order to better prepare for pre-scheduled witness testimony. Requests to testify must be submitted by email to Saurabh Vishnubhakat email@example.com. Based upon the requests received, an agenda for witness testimony will be sent to testifying requesters and posted on the USPTO Web site.
Speakers providing testimony at the hearings should submit a written copy of their testimony for inclusion in the record of the proceedings no later than March 26, 2012.
The public hearings will be available via Web cast. Information about the Web cast will be posted on the USPTO Web site before the public hearing.
To learn more, click here.